Skip to Main Content

Paper Details

Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging.
Eur Urol Oncol
12
2022
GG, Men, National Comprehensive Cancer Network, PATIENT, PCa, PSMA, Prostate-specific Membrane Antigen, Prostate-specific membrane antigen, men, patient, patients, prostate cancer, prostate-specific antigen, prostate-specific membrane antigen
Author NameAffiliation
Ting Martin Mauniversity of california los angeles Medical Center
Andrei Gafitauniversity of california los angeles Medical Center
David Shabsovichuniversity of california los angeles Medical Center
Jesus E Juarezuniversity of california los angeles Medical Center
Tristan GroganDavid Geffen School of Medicine, University of California los angeles
Tristan GroganDavid Geffen School of Medicine, University of California los angeles
Kathleen Nguyenuniversity of california los angeles Medical Center
Robert E Reiteruniversity of california los angeles Medical Center
Matthew B Rettiguniversity of california los angeles Medical Center
Michael L Steinberguniversity of california los angeles Medical Center
Patrick A Kupelianuniversity of california los angeles Medical Center
Felix Y FengUCSF Medical Center
Neil R Parikhuniversity of california los angeles Medical Center
Nicholas G Nickolsuniversity of california los angeles Medical Center
David ElashoffDavid Geffen School of Medicine, University of California los angeles
David ElashoffDavid Geffen School of Medicine, University of California los angeles
Johannes Czerninuniversity of california los angeles Medical Center
Jeremie Calaisuniversity of california los angeles Medical Center
Amar U Kishanuniversity of california los angeles Medical Center
  • 1 - 19

Datasets